Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

Can GLP-1 drugs slow neurodegeneration? New review finds promising signals but limited clinical proof

Emerging evidence suggests widely used metabolic drugs could influence brain aging pathways, yet large clinical trials are still needed to confirm whether they ... Read More
ADS

DISCLOSURE: We may earn a commission when you use one of our coupons/links to make a purchase.